Evidence map›Paper›PMID 23717435›Full record

ArticlePloS one2013

Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic status.

Hamid Aslami, Wilco P Pulskens, Maria T Kuipers, Aafkeline P Bos, André B P van Kuilenburg, Ronald J A Wanders, Jeroen Roelofsen, Joris J T H Roelofs, Raphaela P Kerindongo, Charlotte J P Beurskens and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Hydrogen Sulfide (HPathogens (Basel, Switzerland) · 2025
    Article
  2. HScience advances · 2024
    Article
  3. Mitochondrial Dysfunction in Bacterial Infections.Pathogens (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Gases in Sepsis: Novel Mediators and Therapeutic Targets.International journal of molecular sciences · 2022
    Review
  7. Hydrogen Sulfide and Carbon Monoxide Tolerance in Bacteria.Antioxidants (Basel, Switzerland) · 2021
    Review
  8. Review
  9. Article
  10. The Role of Host-Generated HFrontiers in cellular and infection microbiology · 2020
    Review
  11. Animal Models ofInternational journal of molecular sciences · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The respiratory microbiome of HIV-infected individuals.Expert review of anti-infective therapy · 2016
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Hamid AslamiLaboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, Amsterdam, The Netherlands. h.aslami@amc.uva.nl
Wilco P Pulskens
Maria T Kuipers
Aafkeline P Bos
André B P van Kuilenburg
Ronald J A Wanders
Jeroen Roelofsen
Joris J T H Roelofs
Raphaela P Kerindongo
Charlotte J P Beurskens
Marcus J Schultz
Wim Kulik
Nina C Weber
Nicole P Juffermans
Academic Medical Center · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is characterized by a generalized inflammatory response and organ failure, associated with mitochondrial dysfunction. Hydrogen sulfide donor NaHS has anti-inflammatory properties, is able to reduce metabolism and can preserve mitochondrial morphology and function. Rats were challenged with live Streptococcus pneumonia or saline and infused with NaHS (36 µmol/kg/h) or vehicle. Lung and kidney injury markers were measured as well as mitochondrial function, viability and biogenesis. Infusion of NaHS reduced heart rate and body temperature, indicative of a hypo-metabolic state. NaHS infusion reduced sepsis-related lung and kidney injury, while host defense remained intact, as reflected by unchanged bacterial outgrowth. The reduction in organ injury was associated with a reversal of a fall in active oxidative phosphorylation with a concomitant decrease in ATP levels and ATP/ADP ratio. Preservation of mitochondrial respiration was associated with increased mitochondrial expression of α-tubulin and protein kinase C-ε, which acts as regulators of respiration. Mitochondrial damage was decreased by NaHS, as suggested by a reduction in mitochondrial DNA leakage in the lung. Also, NaHS treatment was associated with upregulation of peroxisome proliferator-activated receptor-γ coactivator 1α, with a subsequent increase in transcription of mitochondrial respiratory subunits. These findings indicate that NaHS reduces organ injury in pneumosepsis, possibly via preservation of oxidative phosphorylation and thereby ATP synthesis as well as by promoting mitochondrial biogenesis. Further studies on the involvement of mitochondria in sepsis are required.

Indexed as

Energy MetabolismAnimalsAnti-Inflammatory AgentsDisease Models, AnimalElectron Transport Complex IHeart RateKidneyLiverLung InjuryMitochondriaMitochondrial TurnoverOxidation-ReductionPneumonia, PneumococcalProtein Kinase C-epsilonRatsRats, Sprague-DawleyAnti-Inflammatory AgentsElectron Transport Complex IPrkce protein, ratProtein Kinase C-epsilonsodium bisulfideSulfidesTubulin

Identifiers

PMID23717435
PMCPMC3662774
OpenAlexW1975567849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.